EClinCloud Wins Excellence Award at the Chengdu International Software Design and Application Competition

The finals of the 18th China Chengdu International Software Design and Application Competition recently concluded. Congratulations to EClinCloud on winning an Excellence Award for its digital clinical research solution for innovative drugs!
The competition attracted participation from well-known domestic and international universities—such as Peking University, Zhejiang University, Sichuan University, and Nanyang Technological University—as well as numerous prominent enterprises and research institutes, comprising
361 teams and more than 2000 contestants. Through the preliminary and semifinal rounds, EClinCloud stood out to earn this honor. This represents strong recognition of EClinCloud's independent R&D and technological innovation capabilities.
Since its founding, EClinCloud has upheld
the philosophy of "bringing effective treatments to patients through technological innovation," providing AI-enabled digital solutions, independently developing an "all-in-one SaaS cloud platform" that delivers data interoperability for clinical trials (including eCOA, CTMS, eTMF, EDC, RTSM, RM, and other products), and offering "clinical endpoint assessment solutions" across therapeutic areas to help clinical studies obtain more accurate assessment results.
Currently, EClinCloud's
AI technology drives continuous iteration and upgrades across the platform's full product line, helping to significantly accelerate clinical trials. Innovations include:
★ Multiple products achieve intelligent quality control, improving verification accuracy and reducing manual intervention;
★ Efficient archiving, substantially improving document processing efficiency, reducing working hours, and increasing efficiency;
★ Automated applications across multiple scenarios, significantly improving data management accuracy and processing speed;
★ Intelligent de-identification technology to ensure data security and privacy...
In addition, EClinCloud has obtained multiple authoritative domestic and international certifications and built a solid data compliance assurance system, effectively ensuring data transferability, effectiveness, authenticity, and accuracy and providing strong support for partners' clinical studies worldwide.
Looking ahead, EClinCloud will continue to leverage its strengths in digital technology,
AI, and big data, while continuously enhancing its service capabilities to help domestic and international pharmaceutical companies and research institutions improve the efficiency and quality of clinical trials.


